LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has informed stock exchanges that its Board of Directors will meet on January 30, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. At the same meeting, the Board will also consider the declaration of a 3rd Interim Dividend on equity shares for the financial year 2025-26, if any. No dividend amount, record date, or other details have been announced at this stage — this is purely an advance intimation of the upcoming board meeting.
Investors should watch for the Q3 results and any dividend announcement on January 30, 2026. The phrase 'if any' means the dividend is not guaranteed, so expectations should be tempered until the board formally decides.